Objective and design: The use of proton pump inhibitors in acid-related diseases such as peptic ulcer or erosive reflux oesophagitis is well established. The aim of the current nationwide, multicentre ...

Many patients hospitalized with severe heart failure are receiving potentially harmful treatment with intravenous fluids, a study has found. Heart failure patients are commonly treated with diuretics ...

ZD1839, a Selective Oral Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor, Is Well Tolerated and Active in Patients With Solid, Malignant Tumors: Results of a Phase I Trial PURPOSE: PV701, a ...

Last week, the Australian Therapeutic Goods Administration added intravenous (IV) fluids to the growing list of medicines in short supply. The shortage is due to higher-than-expected demand and ...

Sapu Nano and Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) today announced that Vuong Trieu, Chief Executive Officer, will present the Company’s Deciparticle™ nanomedicine platform at ...

Hospital systems across the country — including those in North Texas — are conserving IV fluids as the country's largest manufacturer recovers from damage due to Hurricane Helene. Hospitals across ...